Jennifer N. Pritzker net worth and biography

Jennifer Pritzker Biography and Net Worth

Major Shareholder of OrthoPediatrics

Ms. Jennifer Pritzker is the Major Shareholder of OrthoPediatrics.

What is Jennifer N. Pritzker's net worth?: The estimated net worth of Jennifer N. Pritzker is at least $315,693.07 as of August 8th, 2023. Ms. Pritzker owns 11,931 shares of OrthoPediatrics stock worth more than $315,693 as of November 22nd. This net worth approximation does not reflect any other assets that Ms. Pritzker may own. Learn More about Jennifer N. Pritzker's net worth.
How do I contact Jennifer N. Pritzker?: The corporate mailing address for Ms. Pritzker and other OrthoPediatrics executives is 2850 Frontier Drive, Warsaw IN, 46582. OrthoPediatrics can also be reached via phone at (574) 268-6379 and via email at [email protected]. Learn More on Jennifer N. Pritzker's contact information.
Has Jennifer N. Pritzker been buying or selling shares of OrthoPediatrics?: Jennifer N. Pritzker has not been actively trading shares of OrthoPediatrics in the last ninety days. Most recently, on Thursday, December 9th, Jennifer N. Pritzker bought 1,000 shares of OrthoPediatrics stock. The stock was acquired at an average cost of $60.42 per share, with a total value of $60,420.00. Learn More on Jennifer N. Pritzker's trading history.
Who are OrthoPediatrics' active insiders?: OrthoPediatrics' insider roster includes Bernei Berry, III (Director), Stephen Burns (Director), Fred Hite (CFO), Marie Infante (Director), Gregory Odle (EVP), Jennifer Pritzker (Major Shareholder), Terry Schlotterback (Director), and Mark Throdahl (CEO). Learn More on OrthoPediatrics' active insiders.
Are insiders buying or selling shares of OrthoPediatrics?: In the last twelve months, insiders at the sold shares 7 times. They sold a total of 27,253 shares worth more than $770,374.68. The most recent insider tranaction occured on August, 21st when General Counsel Daniel J Gerritzen sold 10,000 shares worth more than $293,000.00. Insiders at OrthoPediatrics own 31.8% of the company. Learn More about insider trades at OrthoPediatrics.
Information on this page was last updated on 8/21/2024.

Jennifer N. Pritzker Insider Trading History at OrthoPediatrics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/9/2021	Buy	1,000	$60.42	$60,420.00
8/27/2021	Buy	400	$64.55	$25,820.00
5/13/2021	Buy	1,500	$57.49	$86,235.00	9,500

Jennifer N. Pritzker Buying and Selling Activity at OrthoPediatrics

OrthoPediatrics Company Overview

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Today's Range

Now: $26.46

$25.38

$26.73

50 Day Range

MA: $26.67

$22.69

$32.28

2 Week Range

Now: $26.46

$22.41

$36.23

Volume

141,733 shs

Average Volume

169,186 shs

Market Capitalization

$640.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.